{"nctId":"NCT04591353","briefTitle":"Trial Comparing Impact of PENG Block on Quality of Recovery Compared to No-block for Primary Total Hip Arthroplasty","startDateStruct":{"date":"2021-02-01","type":"ACTUAL"},"conditions":["Total Hip Arthroplasty"],"count":122,"armGroups":[{"label":"Investigational group (\"PENG Block\" group)","type":"EXPERIMENTAL","interventionNames":["Drug: PENG Block"]},{"label":"Control group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Lidocaine"]}],"interventions":[{"name":"PENG Block","otherNames":[]},{"name":"Lidocaine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients undergoing primary total hip arthroplasty\n* Patients \\>=18 years of age\n* Patients with an American Society of Anesthesiology (ASA) physical status classification of I, II or III\n* Primary THA (first THA operation in the patient's lifetime)\n\nExclusion Criteria:\n\n* Patients with ASA physical status classification 4 or above\n* Patients with allergies/intolerances to local anesthetic\n* Patients with pre-existing neurologic or anatomic deficits in the lower extremity on the side of the surgical site\n* Patients on chronic opioid use or opioid tolerant (The FDA defines a patient as opioid tolerant if for at least 1 week he or she has been receiving oral morphine 60 mg/day; transdermal fentanyl 25 mcg/hour; oral oxycodone 30 mg/day; oral hydromorphone 8 mg/day; oral oxymorphone 25 mg/day; or an equianalgesic dose of any other opioid)\n* Poor understanding of English language.\n* Patients with coexisting coagulopathy\n* Patients that are pharmacologically anticoagulated will be excluded if placement of peripheral nerve block would be contraindicated according to ASRA (American Society for Regional Anesthesia) guidelines","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Recovery After Total Hip Arthroplasty","description":"The quality of recovery-15 is a validated questionnaire to assess postoperative recovery. I Scale is based on 15 questions, each question score range is 0-10 (0 being poor and 10 being excellent) The survey will be conducted at 24 hours after surgery Total score range is 0-150, where a score of 0 would be the worst possible score, and 150 would be the best possible score.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"131.5","spread":null},{"groupId":"OG001","value":"103","spread":null}]}]}]},{"type":"SECONDARY","title":"Evaluating Recovery After Total Hip Arthroplasty","description":"Quality of recovery (QoR) survey at 48 hours after surgery. QoR-15 scores range from 0 (extremely poor quality of recovery) to 150 (excellent quality of recovery).","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"108","spread":null}]}]}]},{"type":"SECONDARY","title":"Average Pain Medicine Required After Surgery.","description":"Measuring the average milligrams of oral morphine equivalent (OME) consumption at 24 and 48 hours after surgery","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37.3","spread":"29.7"},{"groupId":"OG001","value":"59.5","spread":"43.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.1","spread":"40.5"},{"groupId":"OG001","value":"75.4","spread":"57.8"}]}]}]},{"type":"SECONDARY","title":"Pain Scores After Surgery","description":"Pain scores (visual analog scores VAS) in recovery (PACU), 6, 12, 24 and 48 hours after surgery","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"1.5"},{"groupId":"OG001","value":"2.3","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"2.7"},{"groupId":"OG001","value":"2.5","spread":"2.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"2.3"},{"groupId":"OG001","value":"2.0","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"2.3"},{"groupId":"OG001","value":"2.8","spread":"2.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":"1.6"},{"groupId":"OG001","value":"2.7","spread":"2.3"}]}]}]},{"type":"SECONDARY","title":"Ambulation Distance After Surgery","description":"ambulation distance as recorded by physical therapist at 24 and 48 hours after surgery","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"121.3","spread":"75.3"},{"groupId":"OG001","value":"104.0","spread":"72.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"78.9","spread":"47.5"},{"groupId":"OG001","value":"81.2","spread":"52.0"}]}]}]},{"type":"SECONDARY","title":"Total Patients Using Antiemetics After Surgery","description":"use of any medication for nausea or vomiting prevention after surgery","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"19","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":56},"commonTop":[]}}}